“Early Escape” Strategy In RA Trials Is One Response To Placebo Concerns, Centocor Says
This article was originally published in The Pink Sheet Daily
Executive Summary
One response to concerns over the use of placebo therapy in rheumatoid arthritis trials is to exercise an "early escape" strategy, Centocor Executive Director-Immunology Clinical R&D Daniel Baker said